
Samuel E. Dagogo-Jack is a Nigerian-American physician. He is the A.C. Mullins Endowed Professor in Translational Research, Professor of Medicine, and Chief of the Division of Endocrinology, Diabetes, and Metabolism at the University of Tennessee Health Science Center.
He is the director of the Postgraduate Specialist Training Program in Endocrinology, Diabetes, and Metabolism, and of the Clinical Research Unit, Clinical and Translational Research Institute at UTHSC. He was President (Medicine & Science) of the American Diabetes Association in 2015 and is a recipient of the Banting Medal for Leadership from the ADA. In 2015, he was named President, Medicine & Science, for the American Diabetes Association (ADA). He is an editor of the Journal of Clinical Endocrinology & Metabolism.
He developed the first radioimmunoassay for an epidermal growth factor (EGF) in human saliva, isolated EGF from mouse thyroid, and worked on the regulation of EGF in mice and humans. His work with Philip E. Cryer led to the discovery of the hypoglycemia-associated autonomic failure syndrome and development of methodology for reversal of hypoglycemia unawareness.